Guru Ownership Trend
Guru Analysis for Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.8 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.01 M net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 47.3%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 90.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Ovid Therapeutics Inc. (OVID)
Major holders include Steven Cohen ($5.23 M), Renaissance Technologies (RenTech) ($283,795). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.05 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.01 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited OVID. The total reported sell value was $2.69 M.
Yes, 0 managers opened new positions in OVID, and 1 increased their existing holdings. The total reported buy value was $1.68 M.